Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Tumor Cells: A Multifunctional Biomarker
Timothy A. Yap, David Lorente, Aurelius Omlin, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 10, pp. 2553-2568
Open Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

Genetics and biology of prostate cancer
Guocan Wang, Di Zhao, Denise J. Spring, et al.
Genes & Development (2018) Vol. 32, Iss. 17-18, pp. 1105-1140
Open Access | Times Cited: 634
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T. Byrne, Denis Alférez, Frédéric Amant, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 4, pp. 254-268
Open Access | Times Cited: 600
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher, David Lu, Nicole A. Schreiber, et al.
JAMA Oncology (2016) Vol. 2, Iss. 11, pp. 1441-1441
Open Access | Times Cited: 587
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
Feifei Cheng, Li Su, Cheng Qian
Oncotarget (2016) Vol. 7, Iss. 30, pp. 48832-48841
Open Access | Times Cited: 324
Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer
Nuray Gül, Marjolein van Egmond
Cancer Research (2015) Vol. 75, Iss. 23, pp. 5008-5013
Open Access | Times Cited: 185
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
Crescenzo D’Alterio, Stefania Scala, Gabriella Sozzi, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 351-361
Open Access | Times Cited: 182
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber, et al.
European Urology (2016) Vol. 71, Iss. 6, pp. 874-882
Open Access | Times Cited: 164
Drug discovery in advanced prostate cancer: translating biology into therapy
Timothy A. Yap, Alan D. Smith, Roberta Ferraldeschi, et al.
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 10, pp. 699-718
Closed Access | Times Cited: 131
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
Himisha Beltran, Adam Jendrisak, Mark Landers, et al.
Clinical Cancer Research (2015) Vol. 22, Iss. 6, pp. 1510-1519
Open Access | Times Cited: 128
Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory
José Luis García‐Gimenez, Marta Seco-Cervera, Trygve O. Tollefsbol, et al.
Critical Reviews in Clinical Laboratory Sciences (2017) Vol. 54, Iss. 7-8, pp. 529-550
Open Access | Times Cited: 124
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
Shannon L. Werner, Ryon P. Graf, Mark Landers, et al.
Journal of Circulating Biomarkers (2015) Vol. 4, pp. 3-3
Open Access | Times Cited: 116
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations
Francesc Castro-Giner, Sofia Gkountela, Cinzia Donato, et al.
Diagnostics (2018) Vol. 8, Iss. 2, pp. 31-31
Open Access | Times Cited: 116
Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells
Zahra Eslami‐S, Luis Enrique Cortés‐Hernández, Catherine Alix‐Panabières
Cells (2020) Vol. 9, Iss. 8, pp. 1836-1836
Open Access | Times Cited: 106
Extracellular Vesicles as Shuttles of Tumor Biomarkers and Anti-Tumor Drugs
Davide Zocco, Pietro Ferruzzi, Francesco Cappello, et al.
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 98
Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences
Olivier Gires, Nikolas H. Stoecklein
Cellular and Molecular Life Sciences (2014) Vol. 71, Iss. 22, pp. 4393-4402
Open Access | Times Cited: 98
Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?
Sílvia Calabuig-Fariñas, Eloísa Jantus‐Lewintre, Alejandro Herreros‐Pomares, et al.
Translational Lung Cancer Research (2016) Vol. 5, Iss. 5, pp. 466-482
Open Access | Times Cited: 93
Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications
Jiantong Dong, Jie‐Fu Chen, Matthew Smalley, et al.
Advanced Materials (2019) Vol. 32, Iss. 1
Open Access | Times Cited: 93
Revisiting the Roles of Pro-Metastatic EpCAM in Cancer
M. Aiman Mohtar, Saiful Effendi Syafruddin, Siti Hana Nasir, et al.
Biomolecules (2020) Vol. 10, Iss. 2, pp. 255-255
Open Access | Times Cited: 91
Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, et al.
Cancer Informatics (2022) Vol. 21
Open Access | Times Cited: 59
Exosomal ncRNAs in liquid biopsies for lung cancer
Md Sadique Hussain, Gaurav Gupta, Nehmat Ghaboura, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 119983-119983
Closed Access | Times Cited: 15
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
Qingyu Liao, Ruiming Zhang, Zuli Ou, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200762-200762
Open Access | Times Cited: 9
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection
Song Yi Bae, Kaylee J. Kamalanathan, Catalina Galeano‐Garces, et al.
Endocrinology (2024) Vol. 165, Iss. 4
Open Access | Times Cited: 8
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
Elizabeth A. Punnoose, Roberta Ferraldeschi, Edith Szafer‐Glusman, et al.
British Journal of Cancer (2015) Vol. 113, Iss. 8, pp. 1225-1233
Open Access | Times Cited: 87
Role of circulating-tumor DNA analysis in non-small cell lung cancer
Tao Jiang, Shengxiang Ren, Caicun Zhou
Lung Cancer (2015) Vol. 90, Iss. 2, pp. 128-134
Closed Access | Times Cited: 82
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
Iris Lodewijk, Marta Dueñas, Carolina Rubio, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2514-2514
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top